世界の皮膚フィラー・ボツリヌス毒素市場予測(~2025年)

• 英文タイトル:Global Dermal Fillers and Botulinum Toxin Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Dermal Fillers and Botulinum Toxin Market 2020 by Company, Regions, Type and Application, Forecast to 2025「世界の皮膚フィラー・ボツリヌス毒素市場予測(~2025年)」(市場規模、市場予測)調査レポートです。• レポートコード:GIR201114163
• 出版社/出版日:GlobalInfoResearch / 2020年10月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、皮膚フィラー・ボツリヌス毒素の世界市場を調査対象にし、皮膚フィラー・ボツリヌス毒素の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ヒアルロン酸ベースフィラー、非ヒアルロン酸ベースフィラー、ボツリヌス毒素)、用途別分析(美的ボリューム修復、シワ軽減)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Allergan、Grex、Anika、Galderma、HUGEL、Merz、Speciality、Suneva
・企業別売上、市場シェア
・皮膚フィラー・ボツリヌス毒素の地域別市場分析
・皮膚フィラー・ボツリヌス毒素の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・皮膚フィラー・ボツリヌス毒素のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・皮膚フィラー・ボツリヌス毒素のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・皮膚フィラー・ボツリヌス毒素の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・皮膚フィラー・ボツリヌス毒素の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・皮膚フィラー・ボツリヌス毒素の種類別市場規模2015-2020:ヒアルロン酸ベースフィラー、非ヒアルロン酸ベースフィラー、ボツリヌス毒素
・皮膚フィラー・ボツリヌス毒素の用途別市場規模2015-2020:美的ボリューム修復、シワ軽減
・皮膚フィラー・ボツリヌス毒素の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Dermal Fillers and Botulinum Toxin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Dermal Fillers and Botulinum Toxin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Dermal Fillers and Botulinum Toxin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Dermal Fillers and Botulinum Toxin market has been segmented into:
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin

By Application, Dermal Fillers and Botulinum Toxin has been segmented into:
Aesthetic Volume Restoration
Wrinkle Reduction

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermal Fillers and Botulinum Toxin market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermal Fillers and Botulinum Toxin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermal Fillers and Botulinum Toxin market.

The report offers in-depth assessment of the growth and other aspects of the Dermal Fillers and Botulinum Toxin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Dermal Fillers and Botulinum Toxin Market Share Analysis
Dermal Fillers and Botulinum Toxin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermal Fillers and Botulinum Toxin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermal Fillers and Botulinum Toxin sales, revenue and market share for each player covered in this report.

The major players covered in Dermal Fillers and Botulinum Toxin are:
Allergan
Grex
Anika
Galderma
HUGEL
Merz
Speciality
Suneva

レポート目次

Table of Contents

1 Dermal Fillers and Botulinum Toxin Market Overview
1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Classification of Dermal Fillers and Botulinum Toxin by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type in 2019
1.2.3 Hyaluronic Acid Based Fillers
1.2.4 Non-Hyaluronic Acid Based Fillers
1.2.5 Botulinum Toxin
1.3 Global Dermal Fillers and Botulinum Toxin Market by Application
1.3.1 Overview: Global Dermal Fillers and Botulinum Toxin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Aesthetic Volume Restoration
1.3.3 Wrinkle Reduction
1.4 Global Dermal Fillers and Botulinum Toxin Market by Regions
1.4.1 Global Dermal Fillers and Botulinum Toxin Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Dermal Fillers and Botulinum Toxin (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Dermal Fillers and Botulinum Toxin Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Dermal Fillers and Botulinum Toxin Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dermal Fillers and Botulinum Toxin Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Dermal Fillers and Botulinum Toxin Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dermal Fillers and Botulinum Toxin Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.2 Grex
2.2.1 Grex Details
2.2.2 Grex Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Grex SWOT Analysis
2.2.4 Grex Product and Services
2.2.5 Grex Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.3 Anika
2.3.1 Anika Details
2.3.2 Anika Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Anika SWOT Analysis
2.3.4 Anika Product and Services
2.3.5 Anika Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Galderma SWOT Analysis
2.4.4 Galderma Product and Services
2.4.5 Galderma Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.5 HUGEL
2.5.1 HUGEL Details
2.5.2 HUGEL Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 HUGEL SWOT Analysis
2.5.4 HUGEL Product and Services
2.5.5 HUGEL Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merz
2.6.1 Merz Details
2.6.2 Merz Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merz SWOT Analysis
2.6.4 Merz Product and Services
2.6.5 Merz Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.7 Speciality
2.7.1 Speciality Details
2.7.2 Speciality Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Speciality SWOT Analysis
2.7.4 Speciality Product and Services
2.7.5 Speciality Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
2.8 Suneva
2.8.1 Suneva Details
2.8.2 Suneva Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Suneva SWOT Analysis
2.8.4 Suneva Product and Services
2.8.5 Suneva Dermal Fillers and Botulinum Toxin Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Dermal Fillers and Botulinum Toxin Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Dermal Fillers and Botulinum Toxin Players Market Share
3.2.2 Top 10 Dermal Fillers and Botulinum Toxin Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Regions
4.2 North America Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
4.3 Europe Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
4.5 South America Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
5 North America Dermal Fillers and Botulinum Toxin Revenue by Countries
5.1 North America Dermal Fillers and Botulinum Toxin Revenue by Countries (2015-2020)
5.2 USA Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
5.3 Canada Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
5.4 Mexico Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
6 Europe Dermal Fillers and Botulinum Toxin Revenue by Countries
6.1 Europe Dermal Fillers and Botulinum Toxin Revenue by Countries (2015-2020)
6.2 Germany Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
6.3 UK Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
6.4 France Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
6.5 Russia Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
6.6 Italy Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue by Countries
7.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue by Countries (2015-2020)
7.2 China Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
7.3 Japan Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
7.4 Korea Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
7.5 India Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
8 South America Dermal Fillers and Botulinum Toxin Revenue by Countries
8.1 South America Dermal Fillers and Botulinum Toxin Revenue by Countries (2015-2020)
8.2 Brazil Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
8.3 Argentina Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Dermal Fillers and Botulinum Toxin by Countries
9.1 Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue by Countries (2015-2020)
9.2 Saudi Arabia Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
9.3 UAE Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
9.4 Egypt Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
9.5 South Africa Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2015-2020)
10.2 Global Dermal Fillers and Botulinum Toxin Market Forecast by Type (2019-2024)
10.3 Hyaluronic Acid Based Fillers Revenue Growth Rate (2015-2025)
10.4 Non-Hyaluronic Acid Based Fillers Revenue Growth Rate (2015-2025)
10.5 Botulinum Toxin Revenue Growth Rate (2015-2025)
11 Global Dermal Fillers and Botulinum Toxin Market Segment by Application
11.1 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2015-2020)
11.2 Dermal Fillers and Botulinum Toxin Market Forecast by Application (2019-2024)
11.3 Aesthetic Volume Restoration Revenue Growth (2015-2020)
11.4 Wrinkle Reduction Revenue Growth (2015-2020)
12 Global Dermal Fillers and Botulinum Toxin Market Size Forecast (2021-2025)
12.1 Global Dermal Fillers and Botulinum Toxin Market Size Forecast (2021-2025)
12.2 Global Dermal Fillers and Botulinum Toxin Market Forecast by Regions (2021-2025)
12.3 North America Dermal Fillers and Botulinum Toxin Revenue Market Forecast (2021-2025)
12.4 Europe Dermal Fillers and Botulinum Toxin Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue Market Forecast (2021-2025)
12.6 South America Dermal Fillers and Botulinum Toxin Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US




• 英文レポート名:Global Dermal Fillers and Botulinum Toxin Market 2020 by Company, Regions, Type and Application, Forecast to 2025
• 日本語訳:世界の皮膚フィラー・ボツリヌス毒素市場予測(~2025年)
• レポートコード:GIR201114163お問い合わせ(見積依頼・ご注文・質問)